News

Unraveling Celsius Holdings' Exciting Options Activity Trends

Unraveling Celsius Holdings' Exciting Options Activity Trends

Insights into Celsius Holdings' Options Activity

Lately, financial analysts have become quite optimistic about Celsius Holdings. Our review of the options history for Celsius Holdings (NASDAQ: CELH) revealed some fascinating trading activities. Recently, we identified a total of 18 unusual trades that have sparked the curiosity of market participants.

Taking a closer look at the trading trends, we found that approximately 55% of traders held bullish views, while 38% leaned towards bearish sentiments. In our analysis, we noted 13 put options that totaled $875,933, contrasted with 5 call options valued at $231,010. These numbers reflect a variety of trading strategies in play.

Market Speculation and Price Targets

Exploring the Price Range

Upon examining the volume and open interest tied to these options contracts, it seems that key players are targeting a price range between $22.5 and $50.0 for Celsius Holdings in the upcoming quarter. Understanding these price targets can help investors forecast possible market shifts and evaluate their entry points.

Analyzing Volume & Open Interest

Assessing volume and open interest grants traders an advantage in the options market. These indicators shed light on liquidity and the demand for specific strike prices. Over the past month, monitoring the changes in call and put activities has offered valuable insights into the overall market sentiment for Celsius Holdings.

Recent Trends in Volume

During the last 30 days, we documented numerous trades involving options for Celsius Holdings. This encompassed both calls that suggest an optimistic outlook for price increases, and puts that anticipate potential declines.

Large Options Trades for Celsius Holdings

Here are some significant options trades that we've observed recently:

Detailed Trade Analysis

Although tabular data might typically present this information effectively, it's important to highlight the largest options trades that reflected a bullish sentiment, showcasing current market activities:

  • Trade Symbol: CELH, Trade Type: PUT, Sentiment: Bullish, Exp. Date: 10/18/24, Total Trade Price: $97.5K
  • Trade Symbol: CELH, Trade Type: PUT, Sentiment: Bullish, Exp. Date: 03/21/25, Total Trade Price: $92.4K
  • Trade Symbol: CELH, Trade Type: PUT, Sentiment: Bullish, Exp. Date: 11/15/24, Total Trade Price: $89.7K
  • Trade Symbol: CELH, Trade Type: PUT, Sentiment: Bearish, Exp. Date: 03/21/25, Total Trade Price: $75.9K

About Celsius Holdings

Celsius Holdings is a player in the energy drink segment of the global nonalcoholic beverage sector. A remarkable 96% of its revenue comes from sales in North America. The company stands out for its use of natural ingredients designed to enhance metabolism, appealing to fitness enthusiasts and those leading active lifestyles. Celsius offers a range of products, including Celsius Originals drinks and convenient packets for on-the-go consumption.

Additionally, in a significant development in 2022, Celsius formed a 20-year distribution agreement with PepsiCo, which now owns an 8.5% share in the company—this marked a crucial move in its market strategy.

Celsius Holdings' Current Market Situation

Currently, Celsius Holdings has a trading volume of about 7,693,574 shares, with its stock priced at $31.7, down by -3.35%. Recent Relative Strength Index (RSI) figures suggest that the stock might be oversold, which could represent potential buying opportunities for investors.

Next Earnings Report Timeline

The next earnings report is expected to be released in approximately 42 days, prompting many traders to tweak their strategies based on what they anticipate from the upcoming performance results.

Expert Insights and Market Ratings

Five market analysts have recently assigned ratings to Celsius Holdings, leading to a consensus target price of $40.4. Various analysts have provided specific ratings that reflect their outlook:

  • Stifel has a Buy rating with a target of $51.
  • Maxim Group also holds a Buy rating aimed at $50.
  • Roth MKM maintains a Buy rating with a price target of $45.
  • Truist Securities places it under Hold with a price target of $30.
  • B of A Securities suggests an Underperform rating, targeting $26.

Investing in options involves higher risks; however, knowledgeable investors utilize education, adjust their trade strategies, and stay aware of market trends to manage these risks successfully. For continuous updates on options for Celsius Holdings, advanced trading platforms can provide real-time insights, equipping traders with essential market information.

Frequently Asked Questions

What are the recent trading patterns for Celsius Holdings?

The latest trading patterns show a bullish sentiment, with 55% of traders expressing optimism about CELH, while 38% indicated bearish strategies.

What is the price target range for Celsius Holdings?

Market speculation places the price target for Celsius Holdings between $22.5 and $50.0, based on recent trading activity.

What does Celsius Holdings specialize in?

Celsius Holdings focuses on energy drinks and has developed a strong foothold in North America, using natural ingredients that appeal to health-conscious consumers.

How are analysts rating Celsius Holdings?

Analysts provide a mixed review, establishing a consensus target price of $40.4, featuring a combination of Buy, Hold, and Underperform evaluations.

What risks are involved in trading options?

Trading options comes with significant risks, but informed traders can manage these through education, strategic trades, and careful observation of market trends.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Dorman Products: Anticipating Positive Earnings Ahead

Updated Category News Views 264

Optimistic Earnings Outlook for Dorman Products Dorman Products (NASDAQ: DORM) is gearing up to announce its quarterly earnings report soon, generating buzz among investors. The anticipated release date is approaching, and many are keen to see how the company performs. Expectations Surrounding EPS Analysts have set expectations high, forecasting an earnings per share...

Continue Reading
Fission Uranium Corp. Publishes Results from Special Meeting

Updated Category News Views 53

Fission Uranium Corp. Shares Results from Special Meeting Fission Uranium Corp. (TSX: FCU, OTCQX: FCUUF) recently conducted an important meeting with its securityholders. During this special meeting, the company revealed the results of key votes that will shape its future direction and partnership strategies. Shareholders Express Strong Support for Key Resolutions At the...

Continue Reading
Prevounce Health Enhances Integration with Elation Health's EHR

Updated Category News Views 173

Prevounce Health Partners with Elation Health for Enhanced Care The integration between the Prevounce remote care management platform and the Elation electronic health record (EHR) system marks a significant advancement in healthcare technology. This partnership aims to streamline healthcare processes and enhance patient care through technological synergy. Understanding...

Continue Reading
Exploring the Expanding Landscape of Social Media Listening

Updated Category News Views 196

Growing Demand for Social Media Listening The social media listening market is experiencing remarkable growth, expected to surge from USD 8.36 billion in 2023 to USD 27.63 billion by the year 2032. This projection represents a compound annual growth rate (CAGR) of approximately 14.27% during the forecast period. The increasing need for real-time insights into consumer...

Continue Reading
Orthopedic Braces Market Set to Surge to $5.5 Billion by 2030

Updated Category News Views 123

Overview of the Orthopedic Braces and Supports Market The global orthopedic braces and supports market is currently experiencing significant growth, with a valuation of approximately US$3.8 billion in 2024. This market is expected to reach US$5.5 billion by 2030, showcasing a compound annual growth rate (CAGR) of 6.5% across this period. One of the primary factors...

Continue Reading